Clinical trial
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients…
NCT00073411 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00073411 |
|---|---|
| Title | Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression |
| Official title | Duloxetine Versus Escitalopram and Placebo in the Treatment of Patients With Major Depression |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | duloxetine, escitalopram, placebo |
| Enrollment | 675 |
| Start date | Nov 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Nov 21, 2003 |
| Last update posted | Jul 31, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: